Genetics can play a role in a person's odds for Alzheimer's disease, and new research suggests differences in that risk are ...

Through Alzheimer’s screenings, clinicians often refer to a list of symptoms known as the seven A’s, which are anosognosia, ...

Although the FDA has determined lecanemab's benefits outweigh its risks in treating Alzheimer's, the CMS is pressing for more ...

My husband, Roger, is living with Alzheimer's disease. We did not choose this journey, but we have accepted our destiny.

Food and Drug Administration advisors have voted to endorse an Alzheimer’s drug from Eli Lilly. The FDA panel agreed this ...

Both the Metro Nashville Police Department (MNPD) and the Tennessee Bureau of Investigation (TBI) have posted a Silver Alert ...

FDA voted in favor of Eli Lilly and Company's donanemab for early Alzheimer's, but side effects and other issues may affect ...

The Alzheimer’s Disease Association of Kern County has new equipment that will help save lives. The center received a new AED ...

A new Alzheimer’s study by Boston researchers reveals how a person’s family history could be key for identifying people at heightened risk for the disease.

A new study by investigators from Mass General Brigham suggests that whether a person inherits risk of Alzheimer's disease ...

Findings indicate that a person’s maternal versus paternal family history could have a different impact on risk of ...